Transcript Company review

Biofarma. Company review.
About company
BIOFARMA - is leading Ukrainian pharmaceutical enterprise, that produce and develop innovative drugs, made
from human blood plasma, recombinant drugs and medicines on the basis of spore-forming bacteria.
Quality - our main priority, guaranteed by the current system of quality management is aligned with
international standards ISO 9001, ISO 14001.
Production processes brought into conformity with the standards of GMP, as confirmed by the relevant
certificate.
Nowadays, plant processes 80 tons of plasma per year. After building a new fractionation facility, this amount will
increase to 200 tons in 2018 and 420 tons in 2021, respectively.
Biofarma already successfully exporting its drugs to 15 countries, including Vietnam, Kazakhstan, Belarus,
Georgia and others.
In 2012, the investment company Horizon Capital became a shareholder of Biopharma.
Due to this, within 3 years were raise $ 45 million to build new biopharmaceutical facility. Another $ 40 million
will be invested in 2016-2018 years to build plasma fractionation facility.
The overall turnover for 2014 reached UAH 436 million , and by 2015 – UAH 625 million .
Production site structure
Fractionation
of plasma
Products
warehouse
Administration
building
Utilities
R&D laboratory
Quality control
laboratory
Probiotic
production
Raw warehouse
Production site. Preparations in
ampoules, vials, syringes, soft
forms
Production site
Plasma blood drugs
Name
Use of the drug
Albumin
The drug is prescribed for traumatic and operating shocks, burns, hypoproteinemia and hypoalbuminemia
different origins, in diseases of the gastrointestinal tract, acute pancreatitis, operations with extracorporeal
circulation.
Bioven (IVIG)
The drug is used for substitution of immunotherapy in the treatment of primary and secondary
immunodeficiencies and related diseases and for the treatment and prevention of diseases caused by bacterial
and viral infection.
Biocloth А (Factor VIII)
Treatment and prevention of bleeding caused by innate or acquired deficiency of factor VIII (hemophilia A,
inhibitory form of hemophilia A, acquired deficiency of factor VIII, is associated with spontaneous appearance
of inhibitors to factor VIII). Von Willebrand disease with deficiency of factor VIII.
Hemostatic sponge
Local parenchymal and capillary bleeding, bleeding from the bones, muscles and tissues, localized bleeding on
the body surface or in its cavities
Immunoglobulin Rho
(D) human
for prevention in prenatal or postnatal period, and the artificial termination of pregnancy in Rh-negative
women who are not sensitized to the antigen Rho (D);
during amniocentesis;
injuries of the abdomen during pregnancy.
Human normal
immunoglobulin
for the prevention of infections: hepatitis A, measles, influenza, whooping cough, polio and meningococcal
disease, to improve the resistance of the body during convalescence after acute infection with a prolonged
course, lingering pneumonia.
Immunoglobulin
antistaphylococcal
for the treatment of staphylococcal etiology of children and adults
Plasmol
Treatment of neuralgia, neuritis occurring pain syndrome, and asthma, sciatica, arthritis, chronic inflammatory
processes.
Fibrinolysin
Traumatic bleeding in ophthalmic practice - until 4-th day since the intraocular injury. Thrombosis of central
retinal artery or vein and its branches, bleeding into the anterior chamber of the eye, vitreous body, the retina.
Probiotic
Name
Use of drug
Biosporin (vials,
capsoules)
acute intestinal infections (AII), dysbiosis, prevention of septic complications in the
postoperative period, children сhronic recurrent stomatitis .
Bifidumbacterin
(vials)
In case of prolonged intestinal dysfunction, acute intestinal infections, pneumonia, sepsis
and other chronic infectious diseases, acute and chronic inflammatory diseases of the colon
and small intestine (colitis, enterocolitis), occurring against the backdrop of shortage or lack
bifidoflory.
Bificol
(vials)
biocenosis bowel dysfunction of various etiologies.
Lactobacterin
(vials)
for the prevention and treatment of intestinal ecological community of various etiologies;
at obstetrical procedures related to sanitation genital tract nonspecific inflammatory
diseases of the genital and pregnancy prenatal preparation at risk from vaginal secretion
disorders purity to III-IV degree.
Subalin
(vials, capsoules)
acute viral hepatitis A and B and chronic hepatitis B carriers of HBsAg;
patients with bacterial and viral-bacterial meningoencephalitis;
patients with acute intestinal infections caused by pathogenic and opportunistic pathogenic
microorganisms, including antibiotic-resistant;
patients undergoing DCI, in case of separation of pathogenic and opportunistic
microorganisms, as well as bowel dysfunction.
And children:
patients with chronic viral hepatitis B and C of intestinal dysbiosis syndrome endotoxemia.
Recombinant drugs
Name
Use of drug
Betfer
(ampoules,
vials, syringes)
Recurrent plural (multiple) sclerosis, characterized by at least two relapses in the previous two
years and the absence of signs of continuing its progressive course between relapses.
Laferobion
(Injection)
acute and chronic viral hepatitis B, chronic hepatitis C, acute and chronic septic diseases of viral,
herpetic infections of different localization, multiple sclerosis and others.
Laferobion
(nasal spray)
The drug used for the prevention and treatment of influenza and other acute respiratory viral,
bacterial and viral infections in adults and children, including newborns.
Laferobion
(suppository)
For adults: at papilomo viral infections, urogenital mixed infections, precancerous diseases of
the cervix.
For children: acute respiratory infections (ARI), pneumonia (bacterial, viral, chlamydial),
meningitis, sepsis, specific intrauterine infections (chlamydia, herpes, for the treatment of viral
infection Epstein-Barr virus
Somatin (vials)
Substitution therapy for adults with severe growth hormone deficiency. Deficiency of even one
of pituitary hormones, except for prolactin
Filstim (vials,
syringes)
Reducing the duration of infectious complications in children and adults with severe innate,
recurrent or malignant neutropenia, including febrile reaction accompanied patients receiving
cytotoxic chemotherapy agents
Epobiocrin
(ampoules,
vials, syringes)
Children and adults anemia, erythropoiesis